Lion Biotechnologies, Inc. announced it raised $100 Million in an initial filing from an offering of $100 Million

Jun 15, 2016•over 9 years ago

Amount Raised

$100 Million

New YorkBiotechnology

Company Information

Company

Lion Biotechnologies, Inc.

Location

112 WEST 34TH STREET

New York, New York, United States

About

Lion Biotechnologies develops T-cell-based immunotherapy products for the treatment of cancer.

9 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech